CD274 and neoplasm: There are also ongoing basic studies on the biology of CAR-T cells, although no data have been published to date, except for a Polish-Norwegian research team that recently described CAR-T cells targeting inhibitory ligand PD-L1 present on cancer cells and other cells in the tumor microenvironment.